EQBK vs SRPT · P/E 40, rev $215.8M vs rev $1.13B
Equity Bancshares, Inc. (EQBK) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Equity Bancshares, Inc. (EQBK) is a banks - regional company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported EQBK revenue for 2026-06-30 was $215.8M. Net income was $43.4M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. EQBK currently screens at market cap $974.3M and trailing P/E 40.0.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
EQBK currently screens at market cap $974.3M and trailing P/E 40.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the EQBK and SRPT stock pages for the full models.
Not investment advice.